ASH 2024 Update on Leukemia and Myeloid Neoplasm with Dr. Jayastu Senapati

In this episode, we delve into the key clinically relevant abstracts in leukemia and myeloid neoplasms with Dr. Jayastu Senapati from the MD Anderson Cancer Center. Here are the links to the abstracts we discussed: Older AML: Ven+HMA vs 7+3 Abstract 450: https://ash.confex.com/ash/2024/webpr... Abstract 971: https://ash.confex.com/ash/2024/webpr... Abstract 969: https://ash.confex.com/ash/2024/webpr... Venetoclax resistance mechanisms https://pubmed.ncbi.nlm.nih.gov/39478... FLAG-GO vs FLAG-IDA https://ashpublications.org/blood/art... CPX-351: Abstract 55: https://ash.confex.com/ash/2024/webpr... Abstract 60: https://ash.confex.com/ash/2024/webpr... Menin Inhibitors Abstract 211 https://ash.confex.com/ash/2024/webpr... Abstract 212 https://ash.confex.com/ash/2024/webpr... Abstract 213 https://ash.confex.com/ash/2024/webpr... Abstracts 214 https://ash.confex.com/ash/2024/webpr... Abstract 215 https://ash.confex.com/ash/2024/webpr... Abstract 216 https://ash.confex.com/ash/2024/webpr... FLT3 inhibitors Abstract 221: https://ash.confex.com/ash/2024/webpr... MDS Abstract 349: https://ash.confex.com/ash/2024/webpr... ATRA in MDS: https://ash.confex.com/ash/2024/webpr...